Abstract
Under the background of rapid growth in cancer drug expenditure and the challenges to the sustainability of medical insurance funds, Singapore has implemented cancer drug payment reforms. Through collaborative innovation between the Cancer Drug List (CDL) and a multi-level guarantee system, it has achieved the goals of cost control and equitable access. This article reviews and summarizes the background, content, and impact of Singapore's cancer drug payment reforms, introduces the basics of the CDL and its access mechanism, and explores the synergistic effect of the CDL and the multi-level guarantee system in cancer treatment drug payments. Finally, based on the current development of China's multi-level guarantee system, relevant policy recommendations are proposed to provide a reference for further improving the payment mechanism for high-value cancer drugs in China.
Key words
Singapore /
Cancer Drug List /
cancer drug payment reform /
mandatory medical insurance /
commercial supplemental insurance
Cite this article
Download Citations
Collaborative Innovation Between the Expensive Drug Catalog and the Multi-Level Guarantee System——Singapore's Cancer Drug Payment Reform and Its Implications for China[J]. China Health Insurance. 2025, 0(9): 78-85 https://doi.org/10.19546/j.issn.1674-3830.2025.9.009
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 张欣桐,吕兰婷.新加坡多层次医疗保障体系特点及启示[J].中国医疗保险,2024(11):117-125.
[2] Ministry of Health. MediShield Life Reviews[EB/OL]. (2024-10-26)[2025-05-03]. https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/medishield-life/medishield-life-review/.
[3] Ministry of Health. Transitional support for cancer patients[EB/OL]. (2022-09-02)[2025-05-04]. https://www.moh.gov.sg/newsroom/transitional-support-for-cancer-patients/.
[4] Ministry of Health. Parliamentary QA-Cancer Drug List[EB/OL]. (2023-02-23)[2025-05-04]. https://www.moh.gov.sg/newsroom/cancer-drug-list/.
[5] Ministry of Health. Cancer Drug List[EB/OL]. (2025-03-31)[2025-05-04]. https://www.moh.gov.sg/newsroom/cancer-drug-list/.
[6] Ministry of Health. FAQs on cancer treatment financing[EB/OL]. (2025-03-19)[2025-05-11]. https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/medishield-life/faqs-on-cancer-treatment-financing/.
[7] Agency for Care Effectiveness. Methods and process[EB/OL]. (2025-04-22)[2025-05-11]. https://www.ace-hta.gov.sg/resources/process-methods/.
[8] Ministry of Health. Comparison of Integrated Shield Plans[EB/OL]. (2025-02-19)[2025-05-10]. https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/comparision-of-integrated-shield-plans/.
[9] PRUDENTIAL. PRUExtra-Health Insurance Singapore[EB/OL]. (2025-05-01)[2025-05-10]. https://www.prudential.com.sg/products/health-insurance/medical/pruextra.
